These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28301788)
1. Autoimmune rheumatic diseases: recent advances and current challenges. Cicuttini FM Med J Aust; 2017 Mar; 206(5):201-202. PubMed ID: 28301788 [No Abstract] [Full Text] [Related]
2. Advances in targeted therapies XI. Breedveld FC; Kalden JR; Smolen JS Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i1. PubMed ID: 19995739 [No Abstract] [Full Text] [Related]
3. Advances in targeted therapies VIII. Proceedings of the Eighth International Symposium on Advances in Targeted Therapy. April 5-9, 2006. Sorrento, Italy. Breedveld FC; Kalden JR; Smolen JS Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii1-89. PubMed ID: 17038463 [No Abstract] [Full Text] [Related]
4. Advances in targeted therapies XIII. Breedveld FC; Kalden JR; Smolen JS Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i1. PubMed ID: 22460135 [No Abstract] [Full Text] [Related]
6. Recent advances in Pediatric Rheumatology: July 2015-June 2016. Sharma A; Vignesh P; Jindal AK; Gupta A Int J Rheum Dis; 2017 Apr; 20(4):504-509. PubMed ID: 28205425 [No Abstract] [Full Text] [Related]
7. [Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 5. B cell targeting biologics for rheumatic diseases]. Saito K; Tanaka Y Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2991-7. PubMed ID: 22175143 [No Abstract] [Full Text] [Related]
8. Proceedings from the XIth International Symposium on Advances in Targeted Therapies, 22 to 26 April 2009. Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i1-99. PubMed ID: 20310079 [No Abstract] [Full Text] [Related]
9. Special issue on glucocorticoid therapy in rheumatic diseases: introduction. Cutolo M; Chrousos GP; Pincus T Neuroimmunomodulation; 2015; 22(1-2):3-5. PubMed ID: 25227248 [No Abstract] [Full Text] [Related]
10. Drug therapy in adolescents with rheumatic diseases. Schaller JG Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680 [No Abstract] [Full Text] [Related]
11. Local medical treatment in rheumatic diseases. Menkes CJ Curr Rheumatol Rep; 2001 Apr; 3(2):93-4. PubMed ID: 11286663 [No Abstract] [Full Text] [Related]
12. The use of methotrexate in childhood rheumatic diseases. Wallace CA Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564 [No Abstract] [Full Text] [Related]
13. Advances in targeted therapies XII. Preface. Breedveld FC; Kalden JR; Smolen JS Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210 [No Abstract] [Full Text] [Related]
14. Novel immunological targets in rheumatic diseases: clues from current therapies. D'Acquisto F; Rattazzi L; Piras G; Galuppo ML Drug Discov Today; 2014 Aug; 19(8):1155-60. PubMed ID: 24984284 [TBL] [Abstract][Full Text] [Related]
18. Current world literature. Curr Opin Rheumatol; 2013 May; 25(3):398-409. PubMed ID: 23528992 [No Abstract] [Full Text] [Related]
19. Proceedings of the XIIth International Symposium on Advances in Targeted Therapies. April 14-18, 2010. Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1-122. PubMed ID: 21438187 [No Abstract] [Full Text] [Related]
20. Assessing the efficacy and safety of rheumatic disease treatments: obstacles and proposed solutions. Felson DT Arthritis Rheum; 2003 Jul; 48(7):1781-7. PubMed ID: 12847670 [No Abstract] [Full Text] [Related] [Next] [New Search]